The Bone Cancer Research Trust's policy on working with pharmaceutical and medical device companies aims to provide clear principles and guidance about how we work with pharmaceutical companies and medical device companies to help achieve our aims and objectives.

Read our full policy here: Bone Cancer Research Trust Pharmaceutical Policy (Version 2).

This policy was updated in September 2017, the next review date is September 2020.

For more information on this policy, contact us. If you work for a pharmaceutical company and would like to discuss how you could support us, please contact Mat Cottle-Shaw, Head of Fundraising & Communications, on 0113 258 5934.

Further details about the support we receive from pharmaceutical and medical device companies can be found below.

Support received in 2017

  • Takeda £15,000 - Bone Cancer Conference 2017

Support received in 2016

  • None received

Support received in 2015

  • None received

Support received in 2014

  • Takeda £875 - For project input
  • Implantcast £1,500 - Patients and Supporters Conference
  • Takeda £5,000 - Research Strategy Meeting
  • Takeda £5,000 - Patients and Supporters Conference

Support received in 2013

  • None received

Support received in 2012

  • Takeda £2,500 - Patients and Supporters Conference

Support received in 2011

  • Takeda £5,000 - Patients and Supporters Conference

Support received in 2010

  • Takeda £5,000 - Patients and Supporters Conference